

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | COPI coating of Golgi vesicle (GO:0048205) | 6.79020861 |
| 2 | Golgi transport vesicle coating (GO:0048200) | 6.79020861 |
| 3 | maintenance of protein localization in endoplasmic reticulum (GO:0035437) | 5.19727424 |
| 4 | protein retention in ER lumen (GO:0006621) | 4.65516688 |
| 5 | negative regulation of cell killing (GO:0031342) | 4.56174691 |
| 6 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 4.56174691 |
| 7 | positive regulation of gamma-delta T cell activation (GO:0046645) | 4.42394775 |
| 8 | response to peptidoglycan (GO:0032494) | 4.06315134 |
| 9 | neutrophil activation involved in immune response (GO:0002283) | 4.01595159 |
| 10 | retrograde vesicle-mediated transport, Golgi to ER (GO:0006890) | 3.88739932 |
| 11 | regulation of B cell receptor signaling pathway (GO:0050855) | 3.76421201 |
| 12 | COPII vesicle coating (GO:0048208) | 3.73746420 |
| 13 | positive regulation of growth hormone secretion (GO:0060124) | 3.70532760 |
| 14 | cellular extravasation (GO:0045123) | 3.56163470 |
| 15 | detection of other organism (GO:0098543) | 3.54099958 |
| 16 | activation of signaling protein activity involved in unfolded protein response (GO:0006987) | 3.53401500 |
| 17 | regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway (GO:1902235 | 3.53382293 |
| 18 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 3.51097111 |
| 19 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 3.51097111 |
| 20 | modulation by symbiont of host immune response (GO:0052553) | 3.51097111 |
| 21 | positive regulation by symbiont of host defense response (GO:0052509) | 3.51097111 |
| 22 | modulation by symbiont of host defense response (GO:0052031) | 3.51097111 |
| 23 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 3.51097111 |
| 24 | negative regulation of interleukin-12 production (GO:0032695) | 3.48368884 |
| 25 | growth hormone receptor signaling pathway (GO:0060396) | 3.43103065 |
| 26 | detection of molecule of bacterial origin (GO:0032490) | 3.36939909 |
| 27 | ER overload response (GO:0006983) | 3.34622603 |
| 28 | vesicle coating (GO:0006901) | 3.32858787 |
| 29 | positive regulation of nuclease activity (GO:0032075) | 3.25847625 |
| 30 | macrophage activation involved in immune response (GO:0002281) | 3.24761263 |
| 31 | detection of bacterium (GO:0016045) | 3.23271586 |
| 32 | regulation of gamma-delta T cell activation (GO:0046643) | 3.22884525 |
| 33 | neutrophil activation (GO:0042119) | 3.22374830 |
| 34 | positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770) | 3.19387704 |
| 35 | detection of external biotic stimulus (GO:0098581) | 3.15809869 |
| 36 | antigen processing and presentation of endogenous antigen (GO:0019883) | 3.14910293 |
| 37 | negative regulation of lymphocyte mediated immunity (GO:0002707) | 3.14770373 |
| 38 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 3.11527702 |
| 39 | regulation of mast cell activation (GO:0033003) | 3.11213245 |
| 40 | immunoglobulin mediated immune response (GO:0016064) | 3.10670552 |
| 41 | endoplasmic reticulum unfolded protein response (GO:0030968) | 3.08187042 |
| 42 | microglial cell activation (GO:0001774) | 3.03089914 |
| 43 | negative regulation of glycoprotein biosynthetic process (GO:0010561) | 3.02714820 |
| 44 | granulocyte activation (GO:0036230) | 3.01857258 |
| 45 | ER-nucleus signaling pathway (GO:0006984) | 3.01133381 |
| 46 | cellular response to growth hormone stimulus (GO:0071378) | 3.00311926 |
| 47 | cellular response to unfolded protein (GO:0034620) | 3.00098865 |
| 48 | regulation of growth hormone secretion (GO:0060123) | 2.99981120 |
| 49 | ER-associated ubiquitin-dependent protein catabolic process (GO:0030433) | 2.99937766 |
| 50 | positive regulation of mast cell activation (GO:0033005) | 2.99723644 |
| 51 | neutrophil mediated immunity (GO:0002446) | 2.94694700 |
| 52 | macrophage activation (GO:0042116) | 2.94310249 |
| 53 | negative regulation of T cell mediated immunity (GO:0002710) | 2.92563591 |
| 54 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 2.88001626 |
| 55 | regulation of nuclease activity (GO:0032069) | 2.86144650 |
| 56 | regulation of regulatory T cell differentiation (GO:0045589) | 2.85051336 |
| 57 | regulation of interferon-beta biosynthetic process (GO:0045357) | 2.84450432 |
| 58 | B cell receptor signaling pathway (GO:0050853) | 2.83716220 |
| 59 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 2.83530959 |
| 60 | response to host immune response (GO:0052572) | 2.83530959 |
| 61 | UDP-N-acetylglucosamine metabolic process (GO:0006047) | 2.83145253 |
| 62 | peptide hormone processing (GO:0016486) | 2.81402085 |
| 63 | detection of biotic stimulus (GO:0009595) | 2.80834232 |
| 64 | cellular response to topologically incorrect protein (GO:0035967) | 2.80422051 |
| 65 | germinal center formation (GO:0002467) | 2.80064936 |
| 66 | cellular response to ethanol (GO:0071361) | 2.79958263 |
| 67 | exocrine pancreas development (GO:0031017) | 2.79338354 |
| 68 | regulation of gamma-delta T cell differentiation (GO:0045586) | 2.77779946 |
| 69 | regulation of T-helper 2 cell differentiation (GO:0045628) | 2.76755274 |
| 70 | response to muramyl dipeptide (GO:0032495) | 2.76295610 |
| 71 | regulation of mast cell degranulation (GO:0043304) | 2.75847609 |
| 72 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 2.74564507 |
| 73 | regulation of mast cell activation involved in immune response (GO:0033006) | 2.74543679 |
| 74 | macroautophagy (GO:0016236) | 2.73551602 |
| 75 | endocrine pancreas development (GO:0031018) | 2.71806712 |
| 76 | myeloid cell activation involved in immune response (GO:0002275) | 2.70820434 |
| 77 | response to endoplasmic reticulum stress (GO:0034976) | 2.70613075 |
| 78 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 2.69693648 |
| 79 | response to interleukin-15 (GO:0070672) | 2.68929726 |
| 80 | sequestering of metal ion (GO:0051238) | 2.66206655 |
| 81 | interferon-gamma-mediated signaling pathway (GO:0060333) | 2.64348827 |
| 82 | negative regulation of leukocyte mediated immunity (GO:0002704) | 2.63263218 |
| 83 | activated T cell proliferation (GO:0050798) | 2.63086776 |
| 84 | glycoprotein catabolic process (GO:0006516) | 2.63082407 |
| 85 | insulin-like growth factor receptor signaling pathway (GO:0048009) | 2.62056693 |
| 86 | toxin metabolic process (GO:0009404) | 2.61868916 |
| 87 | tolerance induction (GO:0002507) | 2.61835893 |
| 88 | alpha-linolenic acid metabolic process (GO:0036109) | 2.61123758 |
| 89 | valine metabolic process (GO:0006573) | 2.60923034 |
| 90 | negative regulation of interleukin-17 production (GO:0032700) | 2.60422701 |
| 91 | negative regulation of CD4-positive, alpha-beta T cell activation (GO:2000515) | 2.59904174 |
| 92 | positive regulation of mast cell activation involved in immune response (GO:0033008) | 2.59263196 |
| 93 | positive regulation of mast cell degranulation (GO:0043306) | 2.59263196 |
| 94 | regulation of memory T cell differentiation (GO:0043380) | 2.58106415 |
| 95 | regulation of dendritic cell antigen processing and presentation (GO:0002604) | 2.56876030 |
| 96 | positive regulation of B cell differentiation (GO:0045579) | 2.54644870 |
| 97 | negative regulation of glycoprotein metabolic process (GO:1903019) | 2.54488811 |
| 98 | cellular response to vitamin D (GO:0071305) | 2.53952922 |
| 99 | response to defenses of other organism involved in symbiotic interaction (GO:0052173) | 2.53302204 |
| 100 | response to host (GO:0075136) | 2.53302204 |
| 101 | response to host defenses (GO:0052200) | 2.53302204 |
| 102 | negative regulation of T-helper cell differentiation (GO:0045623) | 2.52909897 |
| 103 | negative regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043371) | 2.52909897 |
| 104 | signal peptide processing (GO:0006465) | 2.52537962 |
| 105 | regulation of type B pancreatic cell apoptotic process (GO:2000674) | 2.52332988 |
| 106 | regulation of B cell differentiation (GO:0045577) | 2.51906049 |
| 107 | negative regulation of erythrocyte differentiation (GO:0045647) | 2.51714206 |
| 108 | leukocyte aggregation (GO:0070486) | 2.51596636 |
| 109 | intra-Golgi vesicle-mediated transport (GO:0006891) | 2.50853748 |
| 110 | negative regulation of type 2 immune response (GO:0002829) | 2.49814700 |
| 111 | interferon-gamma production (GO:0032609) | 2.49499725 |
| 112 | cellular response to interleukin-15 (GO:0071350) | 2.49095884 |
| 113 | production of molecular mediator involved in inflammatory response (GO:0002532) | 2.48136873 |
| 114 | negative regulation of adaptive immune response based on somatic recombination of immune receptors b | 2.48104064 |
| 115 | lipopolysaccharide-mediated signaling pathway (GO:0031663) | 2.47983595 |
| 116 | positive regulation of type 2 immune response (GO:0002830) | 2.47438628 |
| 117 | positive regulation of cellular amide metabolic process (GO:0034250) | 2.46242793 |
| 118 | regulation of protein glycosylation (GO:0060049) | 2.46006789 |
| 119 | regulation of tolerance induction (GO:0002643) | 2.44174514 |
| 120 | positive regulation of glycogen biosynthetic process (GO:0045725) | 2.43136124 |
| 121 | myeloid leukocyte mediated immunity (GO:0002444) | 2.43028696 |
| 122 | insulin secretion (GO:0030073) | 2.42135593 |
| 123 | positive regulation of insulin secretion (GO:0032024) | 2.41978603 |
| 124 | negative regulation of interleukin-6 production (GO:0032715) | 2.40353617 |
| 125 | positive regulation of glycolytic process (GO:0045821) | 2.40020751 |
| 126 | Golgi organization (GO:0007030) | 2.39871111 |
| 127 | 4-hydroxyproline metabolic process (GO:0019471) | 2.39664727 |
| 128 | neutrophil chemotaxis (GO:0030593) | 2.39056733 |
| 129 | regulation of interleukin-17 production (GO:0032660) | 2.38248499 |
| 130 | regulation of type 2 immune response (GO:0002828) | 2.38203345 |
| 131 | leukocyte degranulation (GO:0043299) | 2.37805368 |
| 132 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 2.37688918 |
| 133 | L-phenylalanine catabolic process (GO:0006559) | 2.37688918 |
| 134 | nerve growth factor signaling pathway (GO:0038180) | 2.37512157 |
| 135 | leukocyte migration involved in inflammatory response (GO:0002523) | 2.37456449 |
| 136 | regulation of T cell mediated cytotoxicity (GO:0001914) | 2.37078123 |
| 137 | dorsal/ventral axis specification (GO:0009950) | 2.36625902 |
| 138 | positive regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043372) | 2.36515349 |
| 139 | defense response to protozoan (GO:0042832) | 2.36022831 |
| 140 | regulation of leukocyte degranulation (GO:0043300) | 2.36004261 |
| 141 | protein N-linked glycosylation via asparagine (GO:0018279) | 2.34534817 |
| 142 | intestinal cholesterol absorption (GO:0030299) | 2.33147800 |
| 143 | regulation of germinal center formation (GO:0002634) | 2.32970074 |
| 144 | neutrophil migration (GO:1990266) | 2.32913926 |
| 145 | peptidyl-asparagine modification (GO:0018196) | 2.32784114 |
| 146 | positive regulation of toll-like receptor signaling pathway (GO:0034123) | 2.31899208 |
| 147 | regulation of T cell tolerance induction (GO:0002664) | 2.31865841 |
| 148 | tricarboxylic acid metabolic process (GO:0072350) | 2.30617903 |
| 149 | negative regulation of immunoglobulin mediated immune response (GO:0002890) | 2.30012079 |
| 150 | negative regulation of B cell mediated immunity (GO:0002713) | 2.30012079 |
| 151 | endoplasmic reticulum organization (GO:0007029) | 2.29579994 |
| 152 | dendritic cell migration (GO:0036336) | 2.29236346 |
| 153 | regulation of antigen processing and presentation (GO:0002577) | 2.28775506 |
| 154 | cellular response to vitamin (GO:0071295) | 2.28503334 |
| 155 | response to unfolded protein (GO:0006986) | 2.28049836 |
| 156 | ER to Golgi vesicle-mediated transport (GO:0006888) | 2.25711523 |
| 157 | protein carboxylation (GO:0018214) | 2.25150351 |
| 158 | peptidyl-glutamic acid carboxylation (GO:0017187) | 2.25150351 |
| 159 | positive regulation of glucose import (GO:0046326) | 2.24478604 |
| 160 | protein N-linked glycosylation (GO:0006487) | 2.20100393 |
| 161 | response to topologically incorrect protein (GO:0035966) | 2.18482729 |
| 162 | keratan sulfate catabolic process (GO:0042340) | 2.16728127 |
| 163 | protein maturation by protein folding (GO:0022417) | 2.14350536 |
| 164 | type B pancreatic cell development (GO:0003323) | 2.13881940 |
| 165 | L-phenylalanine metabolic process (GO:0006558) | 2.13818964 |
| 166 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 2.13818964 |
| 167 | regulation of fatty acid beta-oxidation (GO:0031998) | 2.13753554 |
| 168 | sulfur amino acid catabolic process (GO:0000098) | 2.12451796 |
| 169 | positive regulation of peptide hormone secretion (GO:0090277) | 2.12212120 |
| 170 | regulation of glucose import in response to insulin stimulus (GO:2001273) | 2.12190503 |
| 171 | positive regulation of respiratory burst (GO:0060267) | 2.11348320 |
| 172 | regulation of glycogen biosynthetic process (GO:0005979) | 2.07134098 |
| 173 | regulation of glucan biosynthetic process (GO:0010962) | 2.07134098 |
| 174 | regulation of cholesterol homeostasis (GO:2000188) | 2.06830421 |
| 175 | homocysteine metabolic process (GO:0050667) | 2.06672369 |
| 176 | positive regulation of fatty acid beta-oxidation (GO:0032000) | 2.06550915 |
| 177 | regulation of vascular endothelial growth factor signaling pathway (GO:1900746) | 2.06472004 |
| 178 | regulation of cellular response to vascular endothelial growth factor stimulus (GO:1902547) | 2.06258840 |
| 179 | positive regulation of peptide secretion (GO:0002793) | 2.04750221 |
| 180 | nitric oxide mediated signal transduction (GO:0007263) | 2.03806963 |
| 181 | positive regulation of glycogen metabolic process (GO:0070875) | 2.02440804 |
| 182 | negative regulation of fatty acid transport (GO:2000192) | 2.01923972 |
| 183 | transcytosis (GO:0045056) | 2.01688830 |
| 184 | positive regulation of vesicle fusion (GO:0031340) | 2.01386546 |
| 185 | chondrocyte development (GO:0002063) | 2.01022051 |
| 186 | phosphatidylinositol phosphorylation (GO:0046854) | 1.99466391 |
| 187 | regulation of polysaccharide biosynthetic process (GO:0032885) | 1.98525704 |
| 188 | regulation of insulin secretion (GO:0050796) | 1.98005339 |
| 189 | protein localization to endosome (GO:0036010) | 1.97417582 |
| 190 | peptide secretion (GO:0002790) | 1.96826855 |
| 191 | positive regulation of fatty acid oxidation (GO:0046321) | 1.96432560 |
| 192 | branched-chain amino acid metabolic process (GO:0009081) | 1.96054405 |
| 193 | positive regulation of glucose transport (GO:0010828) | 1.95808832 |
| 194 | regulation of ER to Golgi vesicle-mediated transport (GO:0060628) | 1.94961776 |
| 195 | hormone catabolic process (GO:0042447) | 1.94538291 |
| 196 | collagen fibril organization (GO:0030199) | 1.93925928 |
| 197 | Golgi vesicle transport (GO:0048193) | 1.93551351 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 4.12874444 |
| 2 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 3.40586558 |
| 3 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 3.10657256 |
| 4 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 3.08517539 |
| 5 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 3.04422944 |
| 6 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 2.82717356 |
| 7 | GATA1_22025678_ChIP-Seq_K562_Human | 2.73817971 |
| 8 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 2.66945787 |
| 9 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 2.55023854 |
| 10 | * SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.46609213 |
| 11 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 2.45817346 |
| 12 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 2.36469921 |
| 13 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 2.31783393 |
| 14 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 2.31240686 |
| 15 | CLOCK_20551151_ChIP-Seq_293T_Human | 2.28974501 |
| 16 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 2.24410304 |
| 17 | RUNX_20019798_ChIP-Seq_JUKART_Human | 2.22566660 |
| 18 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.11230537 |
| 19 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 1.96814593 |
| 20 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 1.96465414 |
| 21 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.96154583 |
| 22 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 1.93341577 |
| 23 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 1.88187518 |
| 24 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 1.87618289 |
| 25 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 1.83836522 |
| 26 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 1.77716592 |
| 27 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 1.77716592 |
| 28 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 1.71873212 |
| 29 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 1.69954733 |
| 30 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 1.65215761 |
| 31 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 1.64423798 |
| 32 | SCL_19346495_ChIP-Seq_HPC-7_Human | 1.62441366 |
| 33 | MYB_26560356_Chip-Seq_TH2_Human | 1.59944331 |
| 34 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.57772076 |
| 35 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.57444951 |
| 36 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 1.57286022 |
| 37 | SPI1_23127762_ChIP-Seq_K562_Human | 1.49803168 |
| 38 | NR3C1_23031785_ChIP-Seq_PC12_Mouse | 1.44354264 |
| 39 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 1.43996863 |
| 40 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.43839438 |
| 41 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 1.43391937 |
| 42 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.41710179 |
| 43 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 1.41641426 |
| 44 | SPI1_23547873_ChIP-Seq_NB4_Human | 1.40436340 |
| 45 | CJUN_26792858_Chip-Seq_BT549_Human | 1.38571699 |
| 46 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.36745461 |
| 47 | EP300_21415370_ChIP-Seq_HL-1_Mouse | 1.36452010 |
| 48 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 1.36407481 |
| 49 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 1.35792279 |
| 50 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 1.35284785 |
| 51 | AHR_22903824_ChIP-Seq_MCF-7_Human | 1.32464641 |
| 52 | AR_21915096_ChIP-Seq_LNCaP-1F5_Human | 1.31604355 |
| 53 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.30717581 |
| 54 | ARNT_22903824_ChIP-Seq_MCF-7_Human | 1.29910803 |
| 55 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.29520420 |
| 56 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 1.29397314 |
| 57 | MTF2_20144788_ChIP-Seq_MESCs_Mouse | 1.28070842 |
| 58 | SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 1.27427118 |
| 59 | GBX2_23144817_ChIP-Seq_PC3_Human | 1.27168135 |
| 60 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.27130095 |
| 61 | GATA3_27048872_Chip-Seq_THYMUS_Human | 1.26680959 |
| 62 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 1.26501308 |
| 63 | GATA3_26560356_Chip-Seq_TH2_Human | 1.26293524 |
| 64 | RXR_22108803_ChIP-Seq_LS180_Human | 1.24445890 |
| 65 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 1.24427044 |
| 66 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 1.24255936 |
| 67 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 1.23638838 |
| 68 | OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.23624118 |
| 69 | WT1_19549856_ChIP-ChIP_CCG9911_Human | 1.23208369 |
| 70 | SOX2_20726797_ChIP-Seq_SW620_Human | 1.22995507 |
| 71 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.21744849 |
| 72 | GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.21635228 |
| 73 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 1.21438792 |
| 74 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 1.20922312 |
| 75 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.20740154 |
| 76 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.20028512 |
| 77 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.19081770 |
| 78 | * FOXA2_19822575_ChIP-Seq_HepG2_Human | 1.18711111 |
| 79 | ER_23166858_ChIP-Seq_MCF-7_Human | 1.18286626 |
| 80 | * FOXA1_21915096_ChIP-Seq_LNCaP-1F5_Human | 1.16785667 |
| 81 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.12934754 |
| 82 | IGF1R_20145208_ChIP-Seq_DFB_Human | 1.12598097 |
| 83 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 1.11966232 |
| 84 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.11686348 |
| 85 | * RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.08919064 |
| 86 | SMRT_27268052_Chip-Seq_Bcells_Human | 1.08008274 |
| 87 | PRDM14_20953172_ChIP-Seq_ESCs_Human | 1.07601716 |
| 88 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.06801770 |
| 89 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.06403445 |
| 90 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.06383466 |
| 91 | TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 1.06080642 |
| 92 | GATA1_19941826_ChIP-Seq_K562_Human | 1.05940948 |
| 93 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.05856734 |
| 94 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 1.05524197 |
| 95 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 1.04600533 |
| 96 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 1.03922855 |
| 97 | BCAT_22108803_ChIP-Seq_LS180_Human | 1.03214699 |
| 98 | * MYB_26560356_Chip-Seq_TH1_Human | 1.03030488 |
| 99 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 1.02885301 |
| 100 | SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.02408368 |
| 101 | RBPJ_22232070_ChIP-Seq_NCS_Mouse | 1.01917283 |
| 102 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 1.01274275 |
| 103 | SMAD4_21799915_ChIP-Seq_A2780_Human | 1.01249554 |
| 104 | EZH2_27294783_Chip-Seq_NPCs_Mouse | 1.00584293 |
| 105 | CEBPD_21427703_ChIP-Seq_3T3-L1_Mouse | 1.00345643 |
| 106 | PU_27001747_Chip-Seq_BMDM_Mouse | 0.99904581 |
| 107 | ERA_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.98417061 |
| 108 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 0.97960347 |
| 109 | NR3C1_21868756_ChIP-Seq_MCF10A_Human | 0.97510972 |
| 110 | TP63_23658742_ChIP-Seq_EP156T_Human | 0.97284905 |
| 111 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 0.96939345 |
| 112 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 0.96939345 |
| 113 | CDX2_21402776_ChIP-Seq_INTESTINAL-VILLUS_Mouse | 0.96231656 |
| 114 | * SOX9_24532713_ChIP-Seq_HFSC_Mouse | 0.95784368 |
| 115 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 0.95643247 |
| 116 | SOX2_21211035_ChIP-Seq_LN229_Gbm | 0.95573781 |
| 117 | VDR_24763502_ChIP-Seq_THP-1_Human | 0.95369899 |
| 118 | GATA2_19941826_ChIP-Seq_K562_Human | 0.93898409 |
| 119 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 0.93703395 |
| 120 | SUZ12_27294783_Chip-Seq_NPCs_Mouse | 0.93284060 |
| 121 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 0.92734886 |
| 122 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 0.92475059 |
| 123 | WT1_25993318_ChIP-Seq_PODOCYTE_Human | 0.91861624 |
| 124 | TP53_18474530_ChIP-ChIP_U2OS_Human | 0.90469265 |
| 125 | TAF15_26573619_Chip-Seq_HEK293_Human | 0.90247333 |
| 126 | EWS-FLI1_20517297_ChIP-Seq_SK-N-MC_Human | 0.90238501 |
| 127 | NANOG_18555785_Chip-Seq_ESCs_Mouse | 0.89765149 |
| 128 | AR_21572438_ChIP-Seq_LNCaP_Human | 0.89621067 |
| 129 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 0.89300061 |
| 130 | TOP2B_26459242_ChIP-Seq_MCF-7_Human | 0.88291078 |
| 131 | AR_25329375_ChIP-Seq_VCAP_Human | 0.88287478 |
| 132 | FOXM1_26456572_ChIP-Seq_MCF-7_Human | 0.88239726 |
| 133 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 0.88083717 |
| 134 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 0.87225437 |
| 135 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 0.87180864 |
| 136 | DROSHA_22980978_ChIP-Seq_HELA_Human | 0.86646439 |
| 137 | P300_19829295_ChIP-Seq_ESCs_Human | 0.86629436 |
| 138 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 0.86223511 |
| 139 | MEIS1_26253404_ChIP-Seq_OPTIC_CUPS_Mouse | 0.85412628 |
| 140 | * FOXA1_25552417_ChIP-Seq_VCAP_Human | 0.85395803 |
| 141 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 0.85233984 |
| 142 | RUNX1_17652178_ChIP-ChIP_JURKAT_Human | 0.85122190 |
| 143 | EBF1_22473956_ChIP-Seq_BONE_MARROW_Mouse | 0.84924250 |
| 144 | FOXP2_23625967_ChIP-Seq_PFSK-1_AND_SK-N-MC_Human | 0.84899077 |
| 145 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 0.84817027 |
| 146 | WT1_20215353_ChIP-ChIP_NEPHRON_PROGENITOR_Mouse | 0.84520983 |
| 147 | TCFCP2L1_18555785_Chip-Seq_ESCs_Mouse | 0.84193411 |
| 148 | CRX_20693478_ChIP-Seq_RETINA_Mouse | 0.83567220 |
| 149 | CTNNB1_20460455_ChIP-Seq_HCT116_Human | 0.83552311 |
| 150 | P53_22387025_ChIP-Seq_ESCs_Mouse | 0.83346027 |
| 151 | OCT4_21477851_ChIP-Seq_ESCs_Mouse | 0.83301284 |
| 152 | DMRT1_21621532_ChIP-ChIP_FETAL_Ovary | 0.82873697 |
| 153 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.82529946 |
| 154 | * BRD4_25478319_ChIP-Seq_HGPS_Human | 0.82396450 |
| 155 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 0.81740600 |
| 156 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 0.81662026 |
| 157 | CMYC_18555785_Chip-Seq_ESCs_Mouse | 0.81632283 |
| 158 | CDX2_22108803_ChIP-Seq_LS180_Human | 0.81386817 |
| 159 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 0.81336973 |
| 160 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 0.80233582 |
| 161 | ZNF274_21170338_ChIP-Seq_K562_Hela | 0.80111236 |
| 162 | NFE2_27457419_Chip-Seq_LIVER_Mouse | 0.79836424 |
| 163 | TCF3/E2A_22897851_ChIP-Seq_JUKARTE6-1_Human | 0.79769775 |
| 164 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 0.79618805 |
| 165 | FLI1_21867929_ChIP-Seq_TH2_Mouse | 0.79411732 |
| 166 | JUN_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.79369670 |
| 167 | SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 0.79247020 |
| 168 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 0.78874125 |
| 169 | GATA3_22897851_ChIP-Seq_JUKARTE6-1_Human | 0.78110372 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0002877_abnormal_melanocyte_morpholog | 3.74469163 |
| 2 | MP0009780_abnormal_chondrocyte_physiolo | 3.61292091 |
| 3 | MP0001835_abnormal_antigen_presentation | 3.49657615 |
| 4 | MP0002909_abnormal_adrenal_gland | 3.18033589 |
| 5 | MP0002139_abnormal_hepatobiliary_system | 3.13192043 |
| 6 | MP0008438_abnormal_cutaneous_collagen | 3.12179412 |
| 7 | MP0010386_abnormal_urinary_bladder | 2.88854217 |
| 8 | MP0003303_peritoneal_inflammation | 2.88528394 |
| 9 | MP0003436_decreased_susceptibility_to | 2.86480125 |
| 10 | MP0005365_abnormal_bile_salt | 2.77540146 |
| 11 | MP0006082_CNS_inflammation | 2.59392342 |
| 12 | MP0002419_abnormal_innate_immunity | 2.48029481 |
| 13 | MP0009785_altered_susceptibility_to | 2.45485387 |
| 14 | MP0003828_pulmonary_edema | 2.44221848 |
| 15 | MP0005000_abnormal_immune_tolerance | 2.41606849 |
| 16 | MP0005671_abnormal_response_to | 2.40555233 |
| 17 | MP0001790_abnormal_immune_system | 2.39017161 |
| 18 | MP0005387_immune_system_phenotype | 2.39017161 |
| 19 | MP0000685_abnormal_immune_system | 2.36110422 |
| 20 | MP0002148_abnormal_hypersensitivity_rea | 2.35144613 |
| 21 | MP0001800_abnormal_humoral_immune | 2.34713216 |
| 22 | MP0006054_spinal_hemorrhage | 2.26433640 |
| 23 | MP0000013_abnormal_adipose_tissue | 2.20781393 |
| 24 | MP0005464_abnormal_platelet_physiology | 2.14935537 |
| 25 | MP0002723_abnormal_immune_serum | 2.14498361 |
| 26 | MP0005220_abnormal_exocrine_pancreas | 2.13721933 |
| 27 | MP0001944_abnormal_pancreas_morphology | 2.12277141 |
| 28 | MP0003183_abnormal_peptide_metabolism | 2.12128488 |
| 29 | MP0004043_abnormal_pH_regulation | 2.11361577 |
| 30 | MP0003283_abnormal_digestive_organ | 2.09752520 |
| 31 | MP0005085_abnormal_gallbladder_physiolo | 2.06985342 |
| 32 | MP0002452_abnormal_antigen_presenting | 2.06885429 |
| 33 | MP0005025_abnormal_response_to | 2.04225019 |
| 34 | MP0005275_abnormal_skin_tensile | 2.00614922 |
| 35 | MP0002693_abnormal_pancreas_physiology | 2.00340156 |
| 36 | MP0002132_abnormal_respiratory_system | 1.99764190 |
| 37 | MP0003705_abnormal_hypodermis_morpholog | 1.95395580 |
| 38 | MP0003195_calcinosis | 1.95024308 |
| 39 | MP0001666_abnormal_nutrient_absorption | 1.93238349 |
| 40 | MP0002420_abnormal_adaptive_immunity | 1.88899094 |
| 41 | MP0009764_decreased_sensitivity_to | 1.87509782 |
| 42 | MP0002837_dystrophic_cardiac_calcinosis | 1.86929700 |
| 43 | MP0001819_abnormal_immune_cell | 1.86558359 |
| 44 | MP0002896_abnormal_bone_mineralization | 1.86286104 |
| 45 | MP0003252_abnormal_bile_duct | 1.85790727 |
| 46 | MP0010234_abnormal_vibrissa_follicle | 1.84271441 |
| 47 | MP0003300_gastrointestinal_ulcer | 1.83489903 |
| 48 | MP0010155_abnormal_intestine_physiology | 1.72059842 |
| 49 | MP0005503_abnormal_tendon_morphology | 1.70188439 |
| 50 | MP0005360_urolithiasis | 1.69788257 |
| 51 | MP0003868_abnormal_feces_composition | 1.69346510 |
| 52 | MP0004947_skin_inflammation | 1.66479328 |
| 53 | MP0002405_respiratory_system_inflammati | 1.64728207 |
| 54 | MP0005058_abnormal_lysosome_morphology | 1.64100040 |
| 55 | MP0010329_abnormal_lipoprotein_level | 1.61326418 |
| 56 | MP0005646_abnormal_pituitary_gland | 1.60281715 |
| 57 | MP0000003_abnormal_adipose_tissue | 1.59114591 |
| 58 | MP0001845_abnormal_inflammatory_respons | 1.57390047 |
| 59 | MP0004782_abnormal_surfactant_physiolog | 1.55695293 |
| 60 | MP0002876_abnormal_thyroid_physiology | 1.53487127 |
| 61 | MP0005397_hematopoietic_system_phenotyp | 1.52268750 |
| 62 | MP0001545_abnormal_hematopoietic_system | 1.52268750 |
| 63 | MP0008875_abnormal_xenobiotic_pharmacok | 1.49757279 |
| 64 | MP0000465_gastrointestinal_hemorrhage | 1.47948765 |
| 65 | MP0002078_abnormal_glucose_homeostasis | 1.47891290 |
| 66 | MP0004130_abnormal_muscle_cell | 1.42847415 |
| 67 | MP0004883_abnormal_blood_vessel | 1.41236735 |
| 68 | MP0009278_abnormal_bone_marrow | 1.40286473 |
| 69 | MP0005164_abnormal_response_to | 1.36048641 |
| 70 | MP0000716_abnormal_immune_system | 1.34269565 |
| 71 | MP0005310_abnormal_salivary_gland | 1.34197633 |
| 72 | MP0003763_abnormal_thymus_physiology | 1.32380829 |
| 73 | MP0001986_abnormal_taste_sensitivity | 1.30116459 |
| 74 | MP0004484_altered_response_of | 1.27477448 |
| 75 | MP0009643_abnormal_urine_homeostasis | 1.26245334 |
| 76 | MP0008961_abnormal_basal_metabolism | 1.24660477 |
| 77 | MP0001765_abnormal_ion_homeostasis | 1.23306307 |
| 78 | MP0008469_abnormal_protein_level | 1.22149738 |
| 79 | MP0002398_abnormal_bone_marrow | 1.22000236 |
| 80 | MP0001958_emphysema | 1.21640068 |
| 81 | MP0002118_abnormal_lipid_homeostasis | 1.21527610 |
| 82 | MP0001851_eye_inflammation | 1.20805159 |
| 83 | MP0000538_abnormal_urinary_bladder | 1.19077448 |
| 84 | MP0005379_endocrine/exocrine_gland_phen | 1.16425226 |
| 85 | MP0000689_abnormal_spleen_morphology | 1.15915890 |
| 86 | MP0003959_abnormal_lean_body | 1.14807546 |
| 87 | MP0001853_heart_inflammation | 1.13409242 |
| 88 | MP0009333_abnormal_splenocyte_physiolog | 1.11851244 |
| 89 | MP0009384_cardiac_valve_regurgitation | 1.11671182 |
| 90 | MP0002006_tumorigenesis | 1.11522785 |
| 91 | MP0000343_altered_response_to | 1.11464868 |
| 92 | MP0004510_myositis | 1.10507617 |
| 93 | MP0005167_abnormal_blood-brain_barrier | 1.10356821 |
| 94 | MP0003690_abnormal_glial_cell | 1.08824698 |
| 95 | MP0001299_abnormal_eye_distance/ | 1.08586953 |
| 96 | MP0001756_abnormal_urination | 1.08025237 |
| 97 | MP0002090_abnormal_vision | 1.07750066 |
| 98 | MP0004858_abnormal_nervous_system | 1.07739301 |
| 99 | MP0005332_abnormal_amino_acid | 1.07255357 |
| 100 | MP0000537_abnormal_urethra_morphology | 1.05944074 |
| 101 | MP0004233_abnormal_muscle_weight | 1.04447052 |
| 102 | MP0004270_analgesia | 1.04197964 |
| 103 | MP0002138_abnormal_hepatobiliary_system | 1.03833691 |
| 104 | MP0005083_abnormal_biliary_tract | 1.03336572 |
| 105 | MP0002254_reproductive_system_inflammat | 0.98471155 |
| 106 | MP0003172_abnormal_lysosome_physiology | 0.98124785 |
| 107 | MP0003221_abnormal_cardiomyocyte_apopto | 0.96038057 |
| 108 | MP0002722_abnormal_immune_system | 0.95737412 |
| 109 | MP0001177_atelectasis | 0.95569107 |
| 110 | MP0003866_abnormal_defecation | 0.95460319 |
| 111 | MP0002429_abnormal_blood_cell | 0.95333245 |
| 112 | MP0003953_abnormal_hormone_level | 0.95134612 |
| 113 | MP0004272_abnormal_basement_membrane | 0.94801456 |
| 114 | MP0003191_abnormal_cellular_cholesterol | 0.94019094 |
| 115 | MP0005166_decreased_susceptibility_to | 0.93794338 |
| 116 | MP0002060_abnormal_skin_morphology | 0.93643702 |
| 117 | MP0003045_fibrosis | 0.92464808 |
| 118 | MP0002295_abnormal_pulmonary_circulatio | 0.90341377 |
| 119 | MP0005375_adipose_tissue_phenotype | 0.89313092 |
| 120 | MP0000604_amyloidosis | 0.89272777 |
| 121 | MP0005535_abnormal_body_temperature | 0.87661735 |
| 122 | MP0001661_extended_life_span | 0.86820052 |
| 123 | MP0001533_abnormal_skeleton_physiology | 0.86606044 |
| 124 | MP0000609_abnormal_liver_physiology | 0.85013243 |
| 125 | MP0002332_abnormal_exercise_endurance | 0.84550033 |
| 126 | MP0005248_abnormal_Harderian_gland | 0.83868608 |
| 127 | MP0008260_abnormal_autophagy | 0.83851978 |
| 128 | MP0000230_abnormal_systemic_arterial | 0.82608392 |
| 129 | MP0002277_abnormal_respiratory_mucosa | 0.82280164 |
| 130 | MP0003329_amyloid_beta_deposits | 0.82013660 |
| 131 | MP0005645_abnormal_hypothalamus_physiol | 0.80735845 |
| 132 | MP0002115_abnormal_skeleton_extremities | 0.80207967 |
| 133 | MP0000249_abnormal_blood_vessel | 0.79649023 |
| 134 | MP0001270_distended_abdomen | 0.79448375 |
| 135 | MP0005448_abnormal_energy_balance | 0.78996244 |
| 136 | MP0008004_abnormal_stomach_pH | 0.78534931 |
| 137 | MP0000920_abnormal_myelination | 0.77171357 |
| 138 | MP0008874_decreased_physiological_sensi | 0.75612222 |
| 139 | MP0005388_respiratory_system_phenotype | 0.75004484 |
| 140 | MP0002133_abnormal_respiratory_system | 0.75004484 |
| 141 | MP0002009_preneoplasia | 0.74993810 |
| 142 | MP0005334_abnormal_fat_pad | 0.74738259 |
| 143 | MP0000681_abnormal_thyroid_gland | 0.74538436 |
| 144 | MP0005636_abnormal_mineral_homeostasis | 0.74252368 |
| 145 | MP0001502_abnormal_circadian_rhythm | 0.74068728 |
| 146 | MP0009763_increased_sensitivity_to | 0.73897088 |
| 147 | MP0002166_altered_tumor_susceptibility | 0.73526202 |
| 148 | MP0005390_skeleton_phenotype | 0.73509855 |
| 149 | MP0003566_abnormal_cell_adhesion | 0.73171669 |
| 150 | MP0000163_abnormal_cartilage_morphology | 0.73080240 |
| 151 | MP0003795_abnormal_bone_structure | 0.72917557 |
| 152 | MP0003656_abnormal_erythrocyte_physiolo | 0.72378366 |
| 153 | MP0001542_abnormal_bone_strength | 0.71870487 |
| 154 | MP0003091_abnormal_cell_migration | 0.71080499 |
| 155 | MP0009765_abnormal_xenobiotic_induced | 0.70925707 |
| 156 | MP0003279_aneurysm | 0.70749920 |
| 157 | MP0002998_abnormal_bone_remodeling | 0.70516789 |
| 158 | MP0000569_abnormal_digit_pigmentation | 0.69573907 |
| 159 | MP0005451_abnormal_body_composition | 0.69458960 |
| 160 | MP0009840_abnormal_foam_cell | 0.68977949 |
| 161 | MP0004084_abnormal_cardiac_muscle | 0.68201692 |
| 162 | MP0002168_other_aberrant_phenotype | 0.68128709 |
| 163 | MP0003075_altered_response_to | 0.68027536 |
| 164 | MP0000516_abnormal_urinary_system | 0.65741040 |
| 165 | MP0005367_renal/urinary_system_phenotyp | 0.65741040 |
| 166 | MP0002928_abnormal_bile_duct | 0.65062915 |
| 167 | MP0001501_abnormal_sleep_pattern | 0.64307928 |
| 168 | MP0003724_increased_susceptibility_to | 0.61503306 |
| 169 | MP0004036_abnormal_muscle_relaxation | 0.59944093 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Stomatitis (HP:0010280) | 4.35408446 |
| 2 | Hypoglycemic seizures (HP:0002173) | 4.03455780 |
| 3 | Eczematoid dermatitis (HP:0000976) | 4.02453608 |
| 4 | Myositis (HP:0100614) | 3.92602060 |
| 5 | Elevated erythrocyte sedimentation rate (HP:0003565) | 3.91761968 |
| 6 | Orchitis (HP:0100796) | 3.87652351 |
| 7 | Optic neuritis (HP:0100653) | 3.85152782 |
| 8 | Retrobulbar optic neuritis (HP:0100654) | 3.85152782 |
| 9 | Abnormality of macrophages (HP:0004311) | 3.81315933 |
| 10 | Hypoglycemic coma (HP:0001325) | 3.80359634 |
| 11 | T lymphocytopenia (HP:0005403) | 3.59137079 |
| 12 | Elevated circulating parathyroid hormone (PTH) level (HP:0003165) | 3.56177261 |
| 13 | Hyperinsulinemic hypoglycemia (HP:0000825) | 3.55310675 |
| 14 | Recurrent abscess formation (HP:0002722) | 3.51766228 |
| 15 | Recurrent bacterial skin infections (HP:0005406) | 3.51628511 |
| 16 | Abnormality of liposaccharide metabolism (HP:0010968) | 3.41846773 |
| 17 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 3.41846773 |
| 18 | Abnormality of glycolipid metabolism (HP:0010969) | 3.41846773 |
| 19 | Abnormality of T cell number (HP:0011839) | 3.39082577 |
| 20 | Recurrent fungal infections (HP:0002841) | 3.36675876 |
| 21 | Symptomatic seizures (HP:0011145) | 3.35039148 |
| 22 | Mediastinal lymphadenopathy (HP:0100721) | 3.33761426 |
| 23 | Hyperglycemia (HP:0003074) | 3.30869246 |
| 24 | Panhypogammaglobulinemia (HP:0003139) | 3.26223901 |
| 25 | Insulin-resistant diabetes mellitus (HP:0000831) | 3.23277900 |
| 26 | Abnormality of the intrinsic pathway (HP:0010989) | 3.19422220 |
| 27 | Ketoacidosis (HP:0001993) | 3.17580931 |
| 28 | Spontaneous hematomas (HP:0007420) | 3.14447212 |
| 29 | Testicular neoplasm (HP:0010788) | 2.95415573 |
| 30 | Urinary glycosaminoglycan excretion (HP:0003541) | 2.95065108 |
| 31 | Mucopolysacchariduria (HP:0008155) | 2.95065108 |
| 32 | Vasculitis (HP:0002633) | 2.92930479 |
| 33 | Episodic fever (HP:0001954) | 2.88767151 |
| 34 | Gastrointestinal infarctions (HP:0005244) | 2.86938475 |
| 35 | Meningitis (HP:0001287) | 2.86549483 |
| 36 | Prolonged bleeding time (HP:0003010) | 2.82936192 |
| 37 | Recurrent gram-negative bacterial infections (HP:0005420) | 2.72963140 |
| 38 | Keratoconjunctivitis sicca (HP:0001097) | 2.70542653 |
| 39 | Gingival bleeding (HP:0000225) | 2.69056159 |
| 40 | Leukocytosis (HP:0001974) | 2.66707246 |
| 41 | Abnormality of the common coagulation pathway (HP:0010990) | 2.66479245 |
| 42 | Dysostosis multiplex (HP:0000943) | 2.65432258 |
| 43 | Abnormality of B cell number (HP:0010975) | 2.65287260 |
| 44 | Eosinophilia (HP:0001880) | 2.65136860 |
| 45 | Thyroiditis (HP:0100646) | 2.64022061 |
| 46 | Keratoconjunctivitis (HP:0001096) | 2.63225962 |
| 47 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 2.62390874 |
| 48 | Abnormality of polysaccharide metabolism (HP:0011012) | 2.60313793 |
| 49 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 2.60313793 |
| 50 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 2.60313793 |
| 51 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 2.60105536 |
| 52 | Pulmonary infiltrates (HP:0002113) | 2.59713895 |
| 53 | Gonadal dysgenesis (HP:0000133) | 2.59574503 |
| 54 | Hemoptysis (HP:0002105) | 2.58505786 |
| 55 | Recurrent skin infections (HP:0001581) | 2.57383110 |
| 56 | Premature rupture of membranes (HP:0001788) | 2.56480517 |
| 57 | Recurrent cutaneous fungal infections (HP:0011370) | 2.56142803 |
| 58 | Chronic mucocutaneous candidiasis (HP:0002728) | 2.56142803 |
| 59 | Type II lissencephaly (HP:0007260) | 2.50576868 |
| 60 | Cerebellar dysplasia (HP:0007033) | 2.49144685 |
| 61 | Chronic obstructive pulmonary disease (HP:0006510) | 2.48468662 |
| 62 | Obstructive lung disease (HP:0006536) | 2.48468662 |
| 63 | Amyloidosis (HP:0011034) | 2.48460435 |
| 64 | Epiphyseal dysplasia (HP:0002656) | 2.47773609 |
| 65 | Increased cerebral lipofuscin (HP:0011813) | 2.47196178 |
| 66 | B lymphocytopenia (HP:0010976) | 2.47181993 |
| 67 | Atrophy/Degeneration involving the corticospinal tracts (HP:0007372) | 2.44972246 |
| 68 | Degeneration of the lateral corticospinal tracts (HP:0002314) | 2.44972246 |
| 69 | Hypoproteinemia (HP:0003075) | 2.43396112 |
| 70 | Buphthalmos (HP:0000557) | 2.42232692 |
| 71 | Abnormality of endocrine pancreas physiology (HP:0012093) | 2.41605872 |
| 72 | Abnormality of the pancreatic islet cells (HP:0006476) | 2.41605872 |
| 73 | Hypoplasia of the thymus (HP:0000778) | 2.41250963 |
| 74 | Congenital glaucoma (HP:0001087) | 2.41072323 |
| 75 | Recurrent viral infections (HP:0004429) | 2.38880167 |
| 76 | Peritonitis (HP:0002586) | 2.38344825 |
| 77 | Encephalitis (HP:0002383) | 2.36670584 |
| 78 | Protuberant abdomen (HP:0001538) | 2.35338059 |
| 79 | Granulocytopenia (HP:0001913) | 2.34855647 |
| 80 | Large for gestational age (HP:0001520) | 2.33270068 |
| 81 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 2.33199898 |
| 82 | Epistaxis (HP:0000421) | 2.32955822 |
| 83 | Ketosis (HP:0001946) | 2.31103408 |
| 84 | Abnormality of T cells (HP:0002843) | 2.28930680 |
| 85 | Loss of speech (HP:0002371) | 2.26058492 |
| 86 | Conjugated hyperbilirubinemia (HP:0002908) | 2.24500567 |
| 87 | Deep venous thrombosis (HP:0002625) | 2.24084139 |
| 88 | Xanthomatosis (HP:0000991) | 2.23793058 |
| 89 | Urticaria (HP:0001025) | 2.23055866 |
| 90 | Abnormality of calcium-phosphate metabolism (HP:0100530) | 2.20823752 |
| 91 | Pulmonary embolism (HP:0002204) | 2.20625658 |
| 92 | Disinhibition (HP:0000734) | 2.19071804 |
| 93 | Abnormality of the peritoneum (HP:0002585) | 2.12324678 |
| 94 | Mitral stenosis (HP:0001718) | 2.11880035 |
| 95 | Abnormality of eosinophils (HP:0001879) | 2.10185894 |
| 96 | Abnormality of the corticospinal tract (HP:0002492) | 2.09590936 |
| 97 | Complement deficiency (HP:0004431) | 2.09300325 |
| 98 | Fat malabsorption (HP:0002630) | 2.09244443 |
| 99 | Severe combined immunodeficiency (HP:0004430) | 2.08629311 |
| 100 | Hematochezia (HP:0002573) | 2.08471201 |
| 101 | Intrahepatic cholestasis (HP:0001406) | 2.07777119 |
| 102 | Late onset (HP:0003584) | 2.06507031 |
| 103 | Mesangial abnormality (HP:0001966) | 2.06095902 |
| 104 | Insulin resistance (HP:0000855) | 2.05033571 |
| 105 | Abnormal foot bone ossification (HP:0010675) | 2.04998629 |
| 106 | Petechiae (HP:0000967) | 2.04328005 |
| 107 | Chest pain (HP:0100749) | 2.02489597 |
| 108 | Cervical subluxation (HP:0003308) | 2.02441056 |
| 109 | Abnormal tarsal ossification (HP:0008369) | 2.02284383 |
| 110 | Disproportionate short-trunk short stature (HP:0003521) | 2.02209598 |
| 111 | Gingivitis (HP:0000230) | 2.02134191 |
| 112 | Abnormality of the pleura (HP:0002103) | 2.01839007 |
| 113 | Arterial thrombosis (HP:0004420) | 2.01372382 |
| 114 | Skin nodule (HP:0200036) | 2.01055384 |
| 115 | Agitation (HP:0000713) | 1.99235205 |
| 116 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 1.98810526 |
| 117 | Gangrene (HP:0100758) | 1.98565201 |
| 118 | Gout (HP:0001997) | 1.97999599 |
| 119 | Hydroxyprolinuria (HP:0003080) | 1.97837163 |
| 120 | Abnormality of proline metabolism (HP:0010907) | 1.97837163 |
| 121 | Pancreatic islet-cell hyperplasia (HP:0004510) | 1.97659734 |
| 122 | Pheochromocytoma (HP:0002666) | 1.95856272 |
| 123 | Polyneuropathy (HP:0001271) | 1.95510956 |
| 124 | Ovoid vertebral bodies (HP:0003300) | 1.95378521 |
| 125 | Beaking of vertebral bodies (HP:0004568) | 1.94438713 |
| 126 | Central scotoma (HP:0000603) | 1.94083179 |
| 127 | Autoimmune thrombocytopenia (HP:0001973) | 1.94005973 |
| 128 | Amyotrophic lateral sclerosis (HP:0007354) | 1.93915217 |
| 129 | Vacuolated lymphocytes (HP:0001922) | 1.92762103 |
| 130 | Stomach cancer (HP:0012126) | 1.91358363 |
| 131 | Joint swelling (HP:0001386) | 1.90124968 |
| 132 | Glomerulopathy (HP:0100820) | 1.89404758 |
| 133 | Hyperactive renin-angiotensin system (HP:0000841) | 1.89261416 |
| 134 | Bundle branch block (HP:0011710) | 1.86901136 |
| 135 | Thoracolumbar scoliosis (HP:0002944) | 1.86882425 |
| 136 | Anomalous pulmonary venous return (HP:0010772) | 1.86045092 |
| 137 | Abdominal distention (HP:0003270) | 1.85936754 |
| 138 | Hypercortisolism (HP:0001578) | 1.82720492 |
| 139 | Asymmetry of the thorax (HP:0001555) | 1.82569789 |
| 140 | Abolished electroretinogram (ERG) (HP:0000550) | 1.81585767 |
| 141 | Dysautonomia (HP:0002459) | 1.80772320 |
| 142 | Increased IgE level (HP:0003212) | 1.80751923 |
| 143 | Neoplasm of the tracheobronchial system (HP:0100552) | 1.79989666 |
| 144 | Irregular vertebral endplates (HP:0003301) | 1.79732678 |
| 145 | Osteomyelitis (HP:0002754) | 1.79526826 |
| 146 | Inflammation of the large intestine (HP:0002037) | 1.78074762 |
| 147 | Lymphangioma (HP:0100764) | 1.74353612 |
| 148 | Osteoarthritis (HP:0002758) | 1.74342143 |
| 149 | Increased CSF protein (HP:0002922) | 1.74198174 |
| 150 | Alveolar cell carcinoma (HP:0006519) | 1.73457776 |
| 151 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 1.71877551 |
| 152 | Abnormality of the pericardium (HP:0001697) | 1.70269345 |
| 153 | Agammaglobulinemia (HP:0004432) | 1.70207542 |
| 154 | Chronic diarrhea (HP:0002028) | 1.70019873 |
| 155 | Protrusio acetabuli (HP:0003179) | 1.69739655 |
| 156 | Bradycardia (HP:0001662) | 1.69690326 |
| 157 | Papillary thyroid carcinoma (HP:0002895) | 1.69239260 |
| 158 | Aplasia/Hypoplasia involving the sinuses (HP:0009120) | 1.68757730 |
| 159 | Hypoplastic ischia (HP:0003175) | 1.68590348 |
| 160 | Lower limb asymmetry (HP:0100559) | 1.68181108 |
| 161 | Abnormality of purine metabolism (HP:0004352) | 1.67292912 |
| 162 | Abnormality of the ischium (HP:0003174) | 1.67086343 |
| 163 | Hand muscle atrophy (HP:0009130) | 1.66589398 |
| 164 | Glucose intolerance (HP:0000833) | 1.66441248 |
| 165 | Termporal pattern (HP:0011008) | 1.66260841 |
| 166 | Insidious onset (HP:0003587) | 1.66260841 |
| 167 | Abnormal pancreas size (HP:0012094) | 1.65878748 |
| 168 | Craniofacial hyperostosis (HP:0004493) | 1.65343866 |
| 169 | Abnormality of the distal phalanges of the toes (HP:0010182) | 1.64365108 |
| 170 | Cortical dysplasia (HP:0002539) | 1.64215588 |
| 171 | Growth hormone excess (HP:0000845) | 1.64208393 |
| 172 | Atrophic scars (HP:0001075) | 1.63809126 |
| 173 | Myocardial infarction (HP:0001658) | 1.62289353 |
| 174 | Prolonged partial thromboplastin time (HP:0003645) | 1.61681595 |
| 175 | Neuroendocrine neoplasm (HP:0100634) | 1.61178633 |
| 176 | Macroorchidism (HP:0000053) | 1.60733086 |
| 177 | Abnormality of the vertebral endplates (HP:0005106) | 1.58816896 |
| 178 | Cupped ribs (HP:0000887) | 1.58307680 |
| 179 | Papilledema (HP:0001085) | 1.56533024 |
| 180 | Broad ribs (HP:0000885) | 1.55645584 |
| 181 | Platyspondyly (HP:0000926) | 1.55607879 |
| 182 | Ectopia lentis (HP:0001083) | 1.55462985 |
| 183 | Epidermoid cyst (HP:0200040) | 1.55309367 |
| 184 | Aortic dissection (HP:0002647) | 1.55024840 |
| 185 | Abnormality of complement system (HP:0005339) | 1.53313780 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | FRK | 3.68829723 |
| 2 | RIPK4 | 3.46126962 |
| 3 | BCKDK | 3.25548016 |
| 4 | PIK3CG | 3.04975945 |
| 5 | INSRR | 2.59329375 |
| 6 | TRIB3 | 2.53869161 |
| 7 | BMPR2 | 2.45926173 |
| 8 | TXK | 2.36359656 |
| 9 | LATS1 | 2.31984943 |
| 10 | TAOK3 | 2.25686345 |
| 11 | MAP3K2 | 2.25325229 |
| 12 | FLT3 | 2.14228128 |
| 13 | AKT3 | 2.13914330 |
| 14 | IRAK4 | 2.13376175 |
| 15 | EPHA3 | 2.09777303 |
| 16 | CAMKK1 | 1.86194923 |
| 17 | IKBKE | 1.85304533 |
| 18 | PDGFRA | 1.84793372 |
| 19 | FER | 1.80745550 |
| 20 | SIK1 | 1.79656849 |
| 21 | FES | 1.79137459 |
| 22 | MAP2K3 | 1.73404736 |
| 23 | BLK | 1.69714246 |
| 24 | CSK | 1.66396311 |
| 25 | ERN1 | 1.63278352 |
| 26 | SGK2 | 1.63000563 |
| 27 | GRK7 | 1.61400151 |
| 28 | SGK3 | 1.57942663 |
| 29 | MAP3K6 | 1.52636090 |
| 30 | RET | 1.50490106 |
| 31 | ERBB3 | 1.50263203 |
| 32 | DAPK2 | 1.48833207 |
| 33 | NTRK1 | 1.48084322 |
| 34 | KIT | 1.47038888 |
| 35 | FGFR3 | 1.46421303 |
| 36 | DDR2 | 1.44439686 |
| 37 | FGFR4 | 1.43746424 |
| 38 | TBK1 | 1.39816972 |
| 39 | YES1 | 1.38371731 |
| 40 | SYK | 1.37144376 |
| 41 | MAP3K3 | 1.35527032 |
| 42 | SCYL2 | 1.35487831 |
| 43 | CAMKK2 | 1.35167947 |
| 44 | MAP4K1 | 1.34937208 |
| 45 | IKBKB | 1.34344080 |
| 46 | BTK | 1.33017344 |
| 47 | DYRK1B | 1.32808755 |
| 48 | PTK6 | 1.31431149 |
| 49 | TNK2 | 1.30206807 |
| 50 | RIPK1 | 1.29818268 |
| 51 | UHMK1 | 1.29802118 |
| 52 | SGK223 | 1.29793872 |
| 53 | SGK494 | 1.29793872 |
| 54 | PIK3CA | 1.29460011 |
| 55 | IRAK2 | 1.27361693 |
| 56 | JAK1 | 1.25963903 |
| 57 | TEC | 1.23276750 |
| 58 | MET | 1.22460876 |
| 59 | PASK | 1.21949791 |
| 60 | WNK4 | 1.20018104 |
| 61 | PRKCH | 1.17767023 |
| 62 | SIK3 | 1.17256278 |
| 63 | FGFR2 | 1.17122675 |
| 64 | HCK | 1.13296550 |
| 65 | LYN | 1.12046209 |
| 66 | PINK1 | 1.11084431 |
| 67 | MAP3K13 | 1.10650078 |
| 68 | PRKD3 | 1.08294703 |
| 69 | PDGFRB | 1.06998202 |
| 70 | NTRK3 | 1.06906783 |
| 71 | HIPK2 | 1.06145125 |
| 72 | PKN2 | 1.05972271 |
| 73 | MAPK15 | 1.03537358 |
| 74 | ADRBK2 | 1.01131641 |
| 75 | IRAK1 | 1.00820588 |
| 76 | GRK6 | 1.00652027 |
| 77 | TESK1 | 1.00324075 |
| 78 | ACVR1B | 0.99761127 |
| 79 | EPHB1 | 0.95284240 |
| 80 | FGR | 0.93540858 |
| 81 | LMTK2 | 0.92854499 |
| 82 | PTK2 | 0.92690041 |
| 83 | ITK | 0.92568136 |
| 84 | PRKD2 | 0.91535598 |
| 85 | JAK2 | 0.91277728 |
| 86 | CSF1R | 0.91072016 |
| 87 | MAPK7 | 0.90108949 |
| 88 | STK38 | 0.89067843 |
| 89 | WNK1 | 0.87780819 |
| 90 | MAPK12 | 0.85804655 |
| 91 | LCK | 0.85371788 |
| 92 | MATK | 0.83618149 |
| 93 | NUAK1 | 0.82584957 |
| 94 | MAP3K5 | 0.82465758 |
| 95 | GSK3A | 0.81292185 |
| 96 | PRKCE | 0.80320942 |
| 97 | MARK1 | 0.77958436 |
| 98 | PAK3 | 0.73942304 |
| 99 | PRKCQ | 0.73509815 |
| 100 | TAOK1 | 0.73407364 |
| 101 | MARK3 | 0.72128856 |
| 102 | MARK2 | 0.71019500 |
| 103 | JAK3 | 0.68038614 |
| 104 | MAP3K14 | 0.65701865 |
| 105 | STK24 | 0.65371528 |
| 106 | CHUK | 0.64624229 |
| 107 | MAP2K1 | 0.63713286 |
| 108 | KSR2 | 0.63253066 |
| 109 | RPS6KA6 | 0.60492736 |
| 110 | GRK1 | 0.60151799 |
| 111 | MYLK | 0.58234024 |
| 112 | RPS6KC1 | 0.57823574 |
| 113 | RPS6KL1 | 0.57823574 |
| 114 | IGF1R | 0.56706283 |
| 115 | TYK2 | 0.55428770 |
| 116 | NEK9 | 0.55227879 |
| 117 | CASK | 0.54782992 |
| 118 | TRPM7 | 0.54280558 |
| 119 | ABL1 | 0.53930949 |
| 120 | BMPR1B | 0.53815890 |
| 121 | RPS6KA2 | 0.52196943 |
| 122 | TTN | 0.51091157 |
| 123 | LRRK2 | 0.49976429 |
| 124 | CDK19 | 0.49933308 |
| 125 | ROCK1 | 0.49695760 |
| 126 | IRAK3 | 0.48008561 |
| 127 | MAP3K7 | 0.47927772 |
| 128 | CDK5 | 0.44554764 |
| 129 | MAP3K1 | 0.44132246 |
| 130 | ADRBK1 | 0.43865881 |
| 131 | MAP2K6 | 0.43641797 |
| 132 | MST1R | 0.43429285 |
| 133 | MAP3K4 | 0.43388533 |
| 134 | FYN | 0.41766610 |
| 135 | PRKAA1 | 0.39429541 |
| 136 | DYRK1A | 0.38682158 |
| 137 | PRKD1 | 0.37399669 |
| 138 | SGK1 | 0.35925665 |
| 139 | ERBB4 | 0.35580987 |
| 140 | STK38L | 0.35298647 |
| 141 | PTK2B | 0.35288160 |
| 142 | PAK2 | 0.33753830 |
| 143 | PDPK1 | 0.32779936 |
| 144 | STK3 | 0.32773743 |
| 145 | WNK3 | 0.31980152 |
| 146 | MINK1 | 0.31582664 |
| 147 | MAP2K4 | 0.31188339 |
| 148 | ZAP70 | 0.29562217 |
| 149 | PRKG2 | 0.29365705 |
| 150 | RPS6KB1 | 0.29246388 |
| 151 | TGFBR2 | 0.29206349 |
| 152 | PRKACG | 0.28774967 |
| 153 | PDK1 | 0.28417118 |
| 154 | FGFR1 | 0.28206038 |
| 155 | NLK | 0.27734076 |
| 156 | MAP3K10 | 0.27209224 |
| 157 | PRPF4B | 0.26927084 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 3.75982979 |
| 2 | Sulfur metabolism_Homo sapiens_hsa00920 | 2.95991040 |
| 3 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 2.28458500 |
| 4 | Leishmaniasis_Homo sapiens_hsa05140 | 2.27621963 |
| 5 | Osteoclast differentiation_Homo sapiens_hsa04380 | 2.21723938 |
| 6 | Graft-versus-host disease_Homo sapiens_hsa05332 | 2.13025103 |
| 7 | Allograft rejection_Homo sapiens_hsa05330 | 2.09141615 |
| 8 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 2.07932999 |
| 9 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 1.96531584 |
| 10 | Protein export_Homo sapiens_hsa03060 | 1.88816907 |
| 11 | Tuberculosis_Homo sapiens_hsa05152 | 1.86676917 |
| 12 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 1.79366887 |
| 13 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 1.78332165 |
| 14 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 1.74805455 |
| 15 | Nitrogen metabolism_Homo sapiens_hsa00910 | 1.74263641 |
| 16 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 1.70639264 |
| 17 | Asthma_Homo sapiens_hsa05310 | 1.69541205 |
| 18 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 1.65093263 |
| 19 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 1.63960402 |
| 20 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 1.56679461 |
| 21 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 1.54078648 |
| 22 | Insulin secretion_Homo sapiens_hsa04911 | 1.51277727 |
| 23 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.47498349 |
| 24 | Primary immunodeficiency_Homo sapiens_hsa05340 | 1.46204461 |
| 25 | Fatty acid degradation_Homo sapiens_hsa00071 | 1.44660611 |
| 26 | Malaria_Homo sapiens_hsa05144 | 1.40961531 |
| 27 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 1.40180461 |
| 28 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 1.36814673 |
| 29 | Tryptophan metabolism_Homo sapiens_hsa00380 | 1.35792056 |
| 30 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 1.34556070 |
| 31 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 1.34130328 |
| 32 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 1.32832143 |
| 33 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.30206424 |
| 34 | Legionellosis_Homo sapiens_hsa05134 | 1.28017331 |
| 35 | Lysosome_Homo sapiens_hsa04142 | 1.26883968 |
| 36 | Fatty acid metabolism_Homo sapiens_hsa01212 | 1.26818742 |
| 37 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 1.25426108 |
| 38 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 1.25192266 |
| 39 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 1.24391611 |
| 40 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 1.24322706 |
| 41 | Insulin resistance_Homo sapiens_hsa04931 | 1.24321416 |
| 42 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 1.24095952 |
| 43 | Other glycan degradation_Homo sapiens_hsa00511 | 1.23261795 |
| 44 | Butanoate metabolism_Homo sapiens_hsa00650 | 1.21748357 |
| 45 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.21622813 |
| 46 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 1.21372660 |
| 47 | TNF signaling pathway_Homo sapiens_hsa04668 | 1.20478259 |
| 48 | Platelet activation_Homo sapiens_hsa04611 | 1.16805147 |
| 49 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 1.13540933 |
| 50 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 1.11763429 |
| 51 | Measles_Homo sapiens_hsa05162 | 1.11683265 |
| 52 | Antigen processing and presentation_Homo sapiens_hsa04612 | 1.11023148 |
| 53 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 1.10568836 |
| 54 | Pertussis_Homo sapiens_hsa05133 | 1.10212509 |
| 55 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 1.09315139 |
| 56 | Arginine biosynthesis_Homo sapiens_hsa00220 | 1.07837413 |
| 57 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 1.07138558 |
| 58 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 1.05428815 |
| 59 | Protein digestion and absorption_Homo sapiens_hsa04974 | 1.05204012 |
| 60 | Influenza A_Homo sapiens_hsa05164 | 1.04173093 |
| 61 | Viral myocarditis_Homo sapiens_hsa05416 | 1.03130777 |
| 62 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 1.02684290 |
| 63 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 1.01410661 |
| 64 | Selenocompound metabolism_Homo sapiens_hsa00450 | 1.00349946 |
| 65 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 1.00109961 |
| 66 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.99068659 |
| 67 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.97502198 |
| 68 | PPAR signaling pathway_Homo sapiens_hsa03320 | 0.94433616 |
| 69 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.92874652 |
| 70 | Fat digestion and absorption_Homo sapiens_hsa04975 | 0.91892357 |
| 71 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 0.91477253 |
| 72 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.91468451 |
| 73 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.91066741 |
| 74 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.88988645 |
| 75 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 0.88610813 |
| 76 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 0.88197346 |
| 77 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 0.86414676 |
| 78 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.84980089 |
| 79 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 0.82879961 |
| 80 | Fatty acid elongation_Homo sapiens_hsa00062 | 0.82643622 |
| 81 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.82199825 |
| 82 | Hepatitis C_Homo sapiens_hsa05160 | 0.82081670 |
| 83 | Circadian rhythm_Homo sapiens_hsa04710 | 0.81651851 |
| 84 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.80808790 |
| 85 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.79074769 |
| 86 | Propanoate metabolism_Homo sapiens_hsa00640 | 0.78973442 |
| 87 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.77493570 |
| 88 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.75806468 |
| 89 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.74685065 |
| 90 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.73596403 |
| 91 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.72951663 |
| 92 | Focal adhesion_Homo sapiens_hsa04510 | 0.72453214 |
| 93 | Hepatitis B_Homo sapiens_hsa05161 | 0.71931820 |
| 94 | Long-term depression_Homo sapiens_hsa04730 | 0.71071331 |
| 95 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 0.71059736 |
| 96 | ECM-receptor interaction_Homo sapiens_hsa04512 | 0.70714208 |
| 97 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.70492499 |
| 98 | Salmonella infection_Homo sapiens_hsa05132 | 0.70201349 |
| 99 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.70122711 |
| 100 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.69529638 |
| 101 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.69070916 |
| 102 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.68871185 |
| 103 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.68640900 |
| 104 | Amoebiasis_Homo sapiens_hsa05146 | 0.68524444 |
| 105 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.68451377 |
| 106 | Herpes simplex infection_Homo sapiens_hsa05168 | 0.68315313 |
| 107 | Prion diseases_Homo sapiens_hsa05020 | 0.67878542 |
| 108 | Bile secretion_Homo sapiens_hsa04976 | 0.67399258 |
| 109 | Peroxisome_Homo sapiens_hsa04146 | 0.67254934 |
| 110 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.66468430 |
| 111 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.66137517 |
| 112 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.65664210 |
| 113 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.65289762 |
| 114 | Endometrial cancer_Homo sapiens_hsa05213 | 0.65282222 |
| 115 | Cholinergic synapse_Homo sapiens_hsa04725 | 0.64605259 |
| 116 | Cocaine addiction_Homo sapiens_hsa05030 | 0.64350610 |
| 117 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.64163641 |
| 118 | Shigellosis_Homo sapiens_hsa05131 | 0.64079261 |
| 119 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.63304979 |
| 120 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 0.63103993 |
| 121 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.62874670 |
| 122 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.62724279 |
| 123 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.60770005 |
| 124 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.59660907 |
| 125 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 0.59581964 |
| 126 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.59258436 |
| 127 | ABC transporters_Homo sapiens_hsa02010 | 0.57858317 |
| 128 | Phagosome_Homo sapiens_hsa04145 | 0.57848250 |
| 129 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.57823215 |
| 130 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.57506661 |
| 131 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 0.57194593 |
| 132 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.56521474 |
| 133 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.56512377 |
| 134 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.55436584 |
| 135 | GABAergic synapse_Homo sapiens_hsa04727 | 0.54966227 |
| 136 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.53845924 |
| 137 | Dopaminergic synapse_Homo sapiens_hsa04728 | 0.53791882 |
| 138 | Glioma_Homo sapiens_hsa05214 | 0.53775545 |
| 139 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.53412022 |
| 140 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.53305963 |
| 141 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.51784727 |
| 142 | Renin secretion_Homo sapiens_hsa04924 | 0.51403532 |
| 143 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.51266007 |
| 144 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.50421253 |
| 145 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.49700465 |
| 146 | Taste transduction_Homo sapiens_hsa04742 | 0.49433990 |
| 147 | Circadian entrainment_Homo sapiens_hsa04713 | 0.49425001 |
| 148 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.47391023 |
| 149 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.47293663 |
| 150 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.46758697 |
| 151 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 0.46180135 |
| 152 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.46027355 |
| 153 | Steroid biosynthesis_Homo sapiens_hsa00100 | 0.45697532 |
| 154 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 0.45491193 |
| 155 | Amphetamine addiction_Homo sapiens_hsa05031 | 0.45136488 |
| 156 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.45105102 |
| 157 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.43986326 |
| 158 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.43951304 |
| 159 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.43812357 |
| 160 | Long-term potentiation_Homo sapiens_hsa04720 | 0.43419940 |
| 161 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.42771156 |
| 162 | Caffeine metabolism_Homo sapiens_hsa00232 | 0.41789449 |
| 163 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.40816536 |
| 164 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 0.40594982 |
| 165 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.40507848 |
| 166 | Folate biosynthesis_Homo sapiens_hsa00790 | 0.39806950 |
| 167 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.39684694 |
| 168 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.39315539 |
| 169 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 0.38897082 |
| 170 | Histidine metabolism_Homo sapiens_hsa00340 | 0.38864438 |
| 171 | Tyrosine metabolism_Homo sapiens_hsa00350 | 0.38337203 |
| 172 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.38203325 |
| 173 | Endocytosis_Homo sapiens_hsa04144 | 0.36392797 |

